Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
4(17%)
Results Posted
64%(9 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_2
13
54%
Ph phase_1
3
13%
Ph phase_4
3
13%
Ph not_applicable
1
4%
Ph phase_3
4
17%

Phase Distribution

3

Early Stage

13

Mid Stage

7

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
3(12.5%)
Phase 2Efficacy & side effects
13(54.2%)
Phase 3Large-scale testing
4(16.7%)
Phase 4Post-market surveillance
3(12.5%)
N/ANon-phased studies
1(4.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

14 of 18 finished

Non-Completion Rate

22.2%

4 ended early

Currently Active

4

trials recruiting

Total Trials

24

all time

Status Distribution
Active(5)
Completed(14)
Terminated(4)
Other(1)

Detailed Status

Completed14
Recruiting4
Withdrawn3
Terminated1
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
4
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (12.5%)
Phase 213 (54.2%)
Phase 34 (16.7%)
Phase 43 (12.5%)
N/A1 (4.2%)

Trials by Status

terminated14%
withdrawn313%
completed1458%
recruiting417%
enrolling_by_invitation14%
unknown14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07568574Not Applicable

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Enrolling By Invitation
NCT06594926Phase 2

Working Out M0 Bipolar Androgen Therapy

Recruiting
NCT06689085Phase 3

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Recruiting
NCT03516812Phase 2

Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer

Completed
NCT04363164Phase 2

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Recruiting
NCT04460872Phase 2

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Recruiting
NCT02248701Phase 2

Testosterone Plus Finasteride Treatment After Spinal Cord Injury

Terminated
NCT03123913Phase 1

Study of Testosterone and rHGH in FSHD

Completed
NCT04026880Phase 3

Testosterone Effects on Pelvic Floor Muscles

Withdrawn
NCT02090114Phase 2

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Completed
NCT03674320Phase 2

Cycled Testosterone Administration During Pulmonary Rehabilitation in Early Stage COPD

Withdrawn
NCT00001079Phase 2

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Completed
NCT01275365Phase 3

Optimizing Protein Intake in Older Americans With Mobility Limitations

Completed
NCT00161304Phase 2

Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency

Completed
NCT02286921Phase 2

Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance

Completed
NCT02734238Phase 4

Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery

Completed
NCT02697188Phase 2

Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men

Completed
NCT00475501Phase 2

5-Alpha Reductase and Anabolic Effects of Testosterone

Completed
NCT00260143Phase 2

Testosterone and Physical Function in HIV+ Men

Completed
NCT01962454Phase 1

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24